A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer

2020 ◽  
Vol 31 (10) ◽  
pp. 1057-1064
Author(s):  
Hui Li ◽  
Yan Liu ◽  
Xianhong Liu ◽  
Dandan Zhao ◽  
Jingjing Liu ◽  
...  
2019 ◽  
Vol 133 ◽  
pp. 145-159 ◽  
Author(s):  
Nishant S. Kulkarni ◽  
Vineela Parvathaneni ◽  
Snehal K. Shukla ◽  
Leonard Barasa ◽  
Jeanette C. Perron ◽  
...  

2019 ◽  
Vol 11 (18) ◽  
pp. 16336-16346 ◽  
Author(s):  
Alexander M. Cryer ◽  
Cheuk Chan ◽  
Anastasia Eftychidou ◽  
Christy Maksoudian ◽  
Mohan Mahesh ◽  
...  

2019 ◽  
Vol 26 (2) ◽  
pp. 1229-1234 ◽  
Author(s):  
Igor P. Oscorbin ◽  
Alexandra S. Shadrina ◽  
Vadim V. Kozlov ◽  
Vladimir E. Voitsitsky ◽  
Maxim L. Filipenko

Sign in / Sign up

Export Citation Format

Share Document